Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-189-4 | CAS number: 1112-39-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Skin irritation (OECD 439 EPISKIN and EpiDerm): not irritating
Eye irritation (OECD 437): non-corrosive
Eye irritation (WoE in vivo studies according or similar to OECD 405): not irritating (RA CAS 1185-55-3 and RA CAS 2031-67-6)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 - 22 Nov 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- June 2021
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- September 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EPISKIN Small model (EPISKIN-SM™)
- Justification for test system used:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimize the need of in vivo testing. One of the validated in vitro skin irritation tests is the EPISKIN test, which is recommended in international guidelines (e.g. OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN Small Model™ (SkinEthic Laboratories, Lyon, France)
- Tissue batch number: 21-EKIN-046
- Production date: 16 Nov 2021
- Date of initiation of testing: on the day of tissue receipt
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: at room temperature
- Temperature of post-treatment incubation: 37.0 ± 1.0°C (actual range 36.4 - 36.9°C)
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: The tissues were washed with phosphate buffered saline to remove residual test item. After rinsing, the cell culture inserts were each dried carefully and moved to a new well on 2 mL pre-warmed maintenance medium until all tissues were dosed and rinsed.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL in PBS
- Incubation time: 3 h ± 5 min at 37°C
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Barrier function: The IC50 determined by MTT test after incubation with SDS was 1.8 mg/mL (acceptance criteria: 1.5 mg/L ≤ IC50 ≤ 3.0 mg/L).
- Morphology: Multi-layered, highly differentiated epidermis consisting of organized basal, spinous and granular layers, and a multilayered stratum corneum. The number of cell layers was 8.
- Contamination: On cells from the donors, the absence of bacteria, fungus and mycoplasma was verified. On blood of the donors, the absence of HIV1 and 2 antibodies, hepatitis C antibodies and hepatitis B antigen HBs were verified.
TESTING OF INTERFERENCE OF THE TEST ITEM WITH THE MTT ENDPOINT
- COLOR INTERFERENCE: The test item was checked for possible color interference before the study was started. 50 µL of the test item or 50 µL sterile Milli-Q water as a negative control was added to 1.0 mL Milli-Q water. The mixture was incubated for at least 1 h at 37.0 ± 1.0°C in the dark. Furthermore, 50 µL of the test item or 50 µL sterile Milli-Q water as a negative control was added to 2.0 mL isopropanol. The mixture was incubated for 2 - 3 h at room temperature with gentle shaking. At the end of the exposure time, the mixtures were centrifuged for 30 sec at 16000 g if needed and the absorbance of the solutions was determined spectrophotometrically at 570 nm in duplicate with the TECAN Infinite® M200 Pro Plate Reader. If after subtraction of the negative control, the OD for the test item solution is >0.08, the test item is considered as possibly interacting with the MTT measurement.
- MTT REDUCTION: The test item was checked for possible direct MTT reduction before the study was started. To assess the ability of the test item to reduce MTT, 50 µL of the test item was added to 1 mL MTT solution (1 mg/mL MTT in phosphate buffered saline). The mixture was incubated for approximately 3 h at 37.0 ± 1.0°C in the dark. A negative control, 50 µL sterile Milli-Q water was tested concurrently. If the MTT solution color turned blue / purple or if a blue / purple precipitate was observed the test item interacts with MTT.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: single experiment
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant (Cat. 2) or corrosive (Cat. 1) to skin if the relative mean viability of 3 individual tissues after 15 min of exposure and 42 h of post incubation is less than or equal to 50%.
- The test substance is considered to be non-irritant (no category) to skin if the relative mean viability of 3 individual tissues after 15 min of exposure and 42 h of post incubation is greater than 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 25 µL
- Concentration: neat test material
NEGATIVE CONTROL
- Amount applied: 25 µL
POSITIVE CONTROL
- Amount applied: 25 µL
- Concentration: 5%
- The positive control was re-spread after 7 min contact time. - Duration of treatment / exposure:
- 15 ± 0.5 min at room temperature
- Duration of post-treatment incubation (if applicable):
- 42 ± 1 h at 37°C
- Number of replicates:
- triplicates for each treatment and control group
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean value of 3 tissues
- Run / experiment:
- 15 min exposure
- Value:
- 114
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: Because no color change was observed in the presence of MTT it was concluded that the test item did not interact with the MTT endpoint. An additional functional check with freeze-killed or viable tissues was not performed.
- Color interference with MTT: Addition of the test item to Milli-Q and isopropanol resulted after subtraction of the blank in an OD of -0.0003 and 0.0011, respectively. Therefore, it was concluded that the test item did not induce color interference.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The absolute mean OD570 of the negative control tissues was within the laboratory historical control data range.
- Acceptance criteria met for positive control: The positive control had a mean cell viability of 2.5% after 15 ± 0.5 min exposure.
- Acceptance criteria met for variability between replicate measurements: The standard deviation value of the percentage viability of three tissues treated identically was ≤ 16%. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- In the EPISKIN test according to OECD TG 439 the relative mean tissue viability obtained after 15 ± 0.5 min treatment with the test item compared to the negative control tissues was 114%. Since the mean relative tissue viability for the test item was above 50%, the test item is considered to be non-irritant.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 - 26 Nov 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- June 2021
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- September 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiDerm Skin Model (EPI-SIT)
- Justification for test system used:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimize the need of in vivo testing. One of the validated in vitro skin irritation tests is the EpiDerm test, which is recommended in international guidelines (e.g. OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm Skin Model (EPI-SIT) (MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia)
- Tissue batch number: 36108
- Date of initiation of testing: on the day of tissue receipt
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 35 ± 1.0 min at 37.0 ± 1.0°C and the remaining period of the 60 ± 1 min test item exposure at room temperature
- Temperature of post-treatment incubation: 37.0°C
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: The tissues were thoroughly rinsed with Dulbecco’s phosphate buffered saline (DPBS) to remove residual test item. If necessary cotton wool swabs were used to remove any remaining test item. After rinsing, the cell culture inserts were each dried carefully and moved to a new well on 0.9 mL pre-warmed maintenance medium until all tissues were dosed and rinsed.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1.0 mg/mL
- Incubation time: 3 h ± 5 min at 37°C
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: The tissue viability was assessed by an MTT QC assay. The determined OD (540-570 nm) was 1.735 ± 0.069 (acceptance criteria: 1.0 - 3.0).
- Barrier function: The barrier function was assessed by determination of the exposure time required to reduce tissue viability by 50% (ET-50) upon application of 100 µL of 1% Triton X-100. The ET-50 value was determined to be 5.47 h (acceptance criteria: 4.77-8.72 h).
- Contamination: The cells used to produce the EpiDerm™ tissue were screened for the presence of viruses (HIV-1, Hepatitis B and C), bacteria, yeast and other fungi. No contamination was detected.
TESTING OF INTERFERENCE OF THE TEST ITEM WITH THE MTT ENDPOINT (done in Episkin test, Study No.20333347)
- COLOR INTERFERENCE: The test item was checked for possible color interference before the study was started. 50 µL of the test item or 50 µL sterile Milli-Q water as a negative control was added to 1.0 mL Milli-Q water. The mixture was incubated for at least 1 h at 37.0 ± 1.0°C in the dark. Furthermore, 50 µL of the test item or 50 µL sterile Milli-Q water as a negative control was added to 2.0 mL isopropanol. The mixture was incubated for 2 - 3 h at room temperature with gentle shaking. At the end of the exposure time, the mixtures were centrifuged for 30 sec at 16000 g if needed and the absorbance of the solutions was determined spectrophotometrically at 570 nm in duplicate with the TECAN Infinite® M200 Pro Plate Reader. If after subtraction of the negative control, the OD for the test item solution is >0.08, the test item is considered as possibly interacting with the MTT measurement.
- MTT REDUCTION: The test item was checked for possible direct MTT reduction before the study was started. To assess the ability of the test item to reduce MTT, 50 µL of the test item was added to 1 mL MTT solution (1 mg/mL MTT in phosphate buffered saline). The mixture was incubated for approximately 3 h at 37.0 ± 1.0°C in the dark. A negative control, 50 µL sterile Milli-Q water was tested concurrently. If the MTT solution color turned blue / purple or if a blue / purple precipitate was observed the test item interacts with MTT.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: single experiment
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant (Cat. 2) or corrosive (Cat. 1) to skin if the relative mean viability of 3 individual tissues after 60 min of exposure and 42 h of post incubation is less than or equal to 50%.
- The test substance is considered to be non-irritant (no category) to skin if the relative mean viability of 3 individual tissues after 60 min of exposure and 42 h of post incubation is greater than 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 30 µL
- Concentration: neat test material
NEGATIVE CONTROL
- Amount applied: 30 µL
POSITIVE CONTROL
- Amount applied: 30 µL
- Concentration: 5% - Duration of treatment / exposure:
- 60 ± 1 min (35 ± 1.0 min at 37.0 ± 1.0°C and the remaining period at room temperature)
- Duration of post-treatment incubation (if applicable):
- 42 h at 37°C
- Number of replicates:
- triplicates for each treatment and control group
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean value of 3 tissues
- Run / experiment:
- 60 min exposure
- Value:
- 76
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: Because no color change was observed in the presence of MTT it was concluded that the test item did not interact with the MTT endpoint. An additional functional check with freeze-killed or viable tissues was not performed.
- Color interference with MTT: Addition of the test item to Milli-Q and isopropanol resulted after subtraction of the blank in an OD of -0.0003 and 0.0011, respectively. Therefore, it was concluded that the test item did not induce color interference.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: One negative control treated skin was considered to be an outlier and results of this skin were omitted (absolute mean OD570 of 0.761). The absolute mean OD570 of the two remaining negative control tissues was within the laboratory historical control data range.
- Acceptance criteria met for positive control: The positive control had a mean cell viability after 60 ± 1 minutes exposure of 3.1%.
- Acceptance criteria met for variability between replicate measurements: The standard deviation value of the percentage viability of three tissues treated identically was ≤ 18%. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- In the EpiDerm test according to OECD TG 439 the relative mean tissue viability obtained after 60 ± 1 min treatment with the test item compared to the negative control tissues was 76%. Since the mean relative tissue viability for the test item was above 50%, the test item is considered to be non-irritant.
Referenceopen allclose all
Table 1: Mean
Absorption in the In Vitro Skin Irritation Test
|
A (OD570) |
B (OD570) |
C (OD570) |
Mean (OD570) |
|
SD |
Negative control |
1.046 |
1.181 |
1.243 |
1.157 |
± |
0.101 |
Test item |
1.127 |
1.351 |
1.483 |
1.320 |
± |
0.180 |
Positive control |
0.026 |
0.031 |
0.029 |
0.028 |
± |
0.003 |
OD = optical density
SD = Standard deviation
Triplicate exposures are indicated by A, B and C.
In this table the values are corrected for background absorption (0.044). Isopropanol was used to measure the background absorption.
Table 2: Mean Tissue
Viability in the In Vitro Skin Irritation Test
|
Mean tissue viability (percentage of control) |
Standard deviation (percentage) |
Negative control |
100 |
8.7 |
Test item |
114 |
16 |
Positive control |
2.5 |
0.2 |
Table 3: Historical Control Data for In Vitro Skin Irritation Studies
|
Negative control (absorption; OD570) |
Positive control (absorption; OD570) |
Range |
0.507 - 1.478 |
0.026 - 0.549 |
Mean |
1.060 |
0.106 |
SD |
0.153 |
0.085 |
n |
159 |
159 |
SD = Standard deviation
n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of May 2018 to May 2021.
Table 1: Mean
Absorption in the In Vitro Skin Irritation Test
|
A (OD570) |
B (OD570) |
C (OD570) |
Mean (OD570) |
|
SD |
Negative control |
1.577 |
-* |
1.687 |
1.632 |
± |
0.078 |
Test item |
1.506 |
1.283 |
0.932 |
1.240 |
± |
0.290 |
Positive control |
0.054 |
0.046 |
0.052 |
0.051 |
± |
0.004 |
OD = optical density
SD = Standard deviation
Triplicate exposures are indicated by A, B and C.
* original OD570 was 0.761
In this table the values are corrected for background absorption (0.044). Isopropanol was used to measure the background absorption.
Table 2: Mean Tissue
Viability in the In Vitro Skin Irritation Test
|
Mean tissue viability (percentage of control) |
Standard deviation (percentage) |
Negative control |
100 |
4.8 |
Test item |
76 |
17.7 |
Positive control |
3.1 |
0.2 |
Table 3: Historical Control Data for In Vitro Skin Irritation Studies
|
Negative control (absorption; OD570) |
Positive control (absorption; OD570) |
Positive control (viability; %) |
Range |
1.333 - 2.386 |
0.052 - 0.165 |
2.70 - 11.0 |
Mean |
1.818 |
0.081 |
4.63 |
SD |
0.257 |
0.023 |
1.77 |
n |
30 |
30 |
30 |
SD = Standard deviation
n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of April 2015 to May 2021.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- Please refer to the attached justification below and the overall justification for grouping of substances attached in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- out of all 3 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: no effects
- Remarks on result:
- no indication of irritation
- Remarks:
- Kreiling and Jung, 1991. CAS 1185-55-3.
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- out of all 3 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- other: no effects
- Remarks on result:
- no indication of irritation
- Remarks:
- Kreiling and Jung, 1991. CAS 1185-55-3.
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- out of all 3 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 3
- Reversibility:
- fully reversible within: 24 h
- Remarks on result:
- no indication of irritation
- Remarks:
- Kreiling and Jung, 1991. CAS 1185-55-3.
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- out of all 3 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- fully reversible within: 24 h
- Remarks on result:
- no indication of irritation
- Remarks:
- Kreiling and Jung, 1991. CAS 1185-55-3.
- Irritant / corrosive response data:
- All together, data from two source substance are available and used in a weight of evidence approach.
Trimethoxy(methyl)silane was found to be only slightly irritating. The test animals showed irritation in response to the undiluted test substance (lacrimation, congestion and oedema of the mucous membrane) which was reversible within 24 hours. Corneal opacity was present in 3 animals, which was also rapidly reversible. At the 30% concentration, the irritation was very slight, some lacrimation and congestion was present in the first 6 hours. At the 10% and 3% concentrations, no signs of irritation were observed (Juloi, L., 1992: CAS 1185-55-3).
For triethoxy(methyl)silane (CAS 2031-67-6) only one out of six animals showed conjuctivae redness with a score of 1 after 24 hours. This was resolved after 48 hours. All other irritation parameter scores were 0 for all reading time points and all animals. - Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- Several studies are available from structural analogue substances CAS 2031-67-6 and CAS 1185-55-3. Slight eye irritation was partly observed which were reversed latest after 48 hours after exposure. As explained in the analogue justification, the differences between the target and the source are unlikely to lead to differences in the eye irritation potential.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9 Nov 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted 26 June 2020
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: slaughterhouse (Vitelco, 's Hertogenbosch, The Netherlands)
- Storage, temperature and transport conditions of ocular tissue: Eyes were collected and transported in physiological saline in a suitable container under cooled conditions.
- Time interval prior to initiating testing: Eyes were tested the day of arrival in the laboratory.
- Indication of any existing defects or lesions in ocular tissue samples: no
- Indication of any antibiotics used: no
- Quality check of the isolated corneas: The eyes were checked for unacceptable defects, such as opacity, scratches, pigmentation and neovascularization by removing them from the physiological saline and holding them in the light. Those exhibiting defects were discarded.
- Selection and preparation of corneas: The isolated corneas were stored in a petri dish with cMEM (Eagle’s Minimum Essential Medium containing 1% (v/v) L-glutamine and 1% (v/v) Foetal Bovine Serum).
The isolated corneas were mounted in a corneal holder (one cornea per holder) with the endothelial side against the O-ring of the posterior half of the holder. The anterior half of the holder was positioned on top of the cornea and tightened with screws. The compartments of the corneal holder were filled with cMEM of 32 ± 1°C. The corneas were incubated for the minimum of 1 hour at 32 ± 1°C.
After the incubation period, the medium was removed from both compartments and replaced with fresh cMEM. Opacity determinations were performed on each of the corneas using an opacitometer. The opacity of each cornea was read against a cMEM-filled chamber, and the initial opacity reading thus determined was recorded. Corneas that had an initial opacity reading higher than 7 were not used. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 750 µL
- Concentration: neat
Negative and positive control
- Amount(s) applied: 750 µL
- Duration of treatment / exposure:
- 10 ± 1 min at 32 ± 1°C
- Duration of post- treatment incubation (in vitro):
- 120 ± 10 minutes at 32 ± 1°C
- Number of animals or in vitro replicates:
- triplicates for each treatment and control groups
- Details on study design:
- TREATMENT METHOD:
The medium from the anterior compartment was removed and 750 µL of either the negative control, positive control or test item was introduced onto the epithelium of the cornea. The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the control or the test item over the entire cornea. Corneas were incubated in a horizontal position for 10 ± 1 minutes at 32 ± 1°C.
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: After the incubation the solutions were removed and the epithelium was washed with MEM with phenol red (Eagle’s Minimum Essential Medium, Life Technologies) and thereafter with cMEM. Possible pH effects of the test item on the corneas were recorded. The medium in the posterior compartment was removed and both compartments were refilled with fresh cMEM. Subsequently the corneas were incubated for 120 ± 10 minutes at 32 ± 1°C.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: The opacity of a cornea was measured by the diminution of light passing through the cornea.
The light was measured as illuminance (I = luminous flux per area, unit: lux) by a light meter.
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of a microtiter plate reader (OD490)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS) = mean opacity value + (15 x mean OD490 value)
DECISION CRITERIA:
Test substance with an IVIS > 55 was regarded as serious eye damage and labelled Category 1 according to CLP/EPS/GHS.
Test substance with an IVIS ≤ 3 was regarded as non-irritant and labelled in no category.
Test substance with an IVIS > 3; ≤ 55 no prediction can be made. - Irritation parameter:
- in vitro irritation score
- Remarks:
- mean value of 3 corneas
- Run / experiment:
- 10 min exposure
- Value:
- 16
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- no definite prediction on ocular irritation can be made
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: The corneas treated with the positive control and test item were observed to be turbid after the 10 min treatment.
- pH effects: No pH effects of the negative and positive controls as well as of the test item were observed on the rinsing of the corneas with MEM (with phenol red).
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes for two negative controls: the negative control responses resulted in opacity and permeability values that were less than the upper limits of the laboratory historical range. One of the negative control eyes was excluded from the analysis since the permeability was increased. This resulted in an IVIS above the cut-off value of 3.0. This had no impact on the study validity.
- Acceptance criteria met for positive control: yes: the positive control gave an in vitro irritancy score that fell within two standard deviations of the current historical mean. - Interpretation of results:
- other: non-corrosive
- Conclusions:
- In a BCOP test according to OECD TG 437 and in compliance with GLP, dimethoxy(dimethyl)silane induced ocular irritation as assessed for both endpoints (corneal opacity and
permeability), resulting in a mean in vitro irritancy score (IVIS) of 16 after 10 minutes of treatment. Since the test substance induced an IVIS > 3 ≤ 55, no definitive prediction on ocular irritation can be made.
Referenceopen allclose all
Table 1: Summary of Opacity, Permeability and In Vitro Scores
Treatment |
Mean Opacity1 |
Mean Permeability1 |
Mean In vitro Irritation Score1, 2 |
Negative control |
-0.3 |
-0.018 |
-0.6 |
Positive control (Ethanol) |
19 |
1.110 |
36 |
Test item |
8.7 |
0.474 |
16 |
1 Calculated using the negative control corrected mean opacity and mean permeability values for the positive control and test item.
2 In vitro irritancy score (IVIS) = mean opacity value + (15 x mean OD490 value).
Table 2: Opacity Score
Treatment |
Opacity before treatment |
Opacity after treatment |
Final Opacity1 |
Negative control corrected Final Opacity2 |
Mean Final Opacity |
Negative control |
3.7* |
2.5* |
-1.2* |
|
-0.3
|
1.9 |
2.1 |
0.2 |
|||
1.9 |
1.0 |
-0.9 |
|||
Positive control |
3.4 |
22.5 |
19.1 |
19 |
19
|
1.5 |
17.5 |
15.9 |
16 |
||
3.5 |
25.8 |
22.3 |
22 |
||
Test item |
2.7 |
10.5 |
7.8 |
7.8 |
8.7 |
2.2 |
11.2 |
9.0 |
9.0 |
||
0.9 |
10.0 |
9.1 |
9.1 |
Calculations are made without rounding off.
1 Final Opacity = Opacity after treatment – Opacity before treatment.
2 Negative control corrected Final Opacity = Final opacity – Mean final opacity negative control.
3 In case the mean final opacity of the negative control is below zero, no correction will be made.
* Excluded from analysis.
Table 3: Permeability Score Individual Values (Uncorrected)
Treatment |
Dilution factor |
OD490 |
OD490 |
OD490 |
Average OD |
Final OD |
Mean final negative control |
1 |
2 |
3 |
|||||
Negative control |
1 |
0.583* |
0.589* |
0.587* |
0.586* |
0.586*1 |
-0.018 |
1 |
-0.011 |
-0.020 |
-0.018 |
-0.016 |
-0.016 |
||
1 |
-0.022 |
-0.019 |
-0.020 |
-0.020 |
-0.020 |
||
Positive control |
1 |
1.381 |
1.378 |
1.380 |
1.380 |
1.380 |
|
1 |
1.051 |
1.042 |
1.040 |
1.044 |
1.044 |
|
|
1 |
0.853 |
0.852 |
0.852 |
0.852 |
0.852 |
|
|
Test item |
1 |
0.400 |
0.395 |
0.394 |
0.396 |
0.396 |
|
1 |
0.477 |
0.477 |
0.481 |
0.478 |
0.478 |
|
|
1 |
0.496 |
0.493 |
0.486 |
0.492 |
0.492 |
|
* Excluded from analysis.
Calculations are made without rounding off.
Table 4: Permeability Score Individual Values (Corrected)
Treatment |
Dilution factor |
Negative control corrected OD490 1# |
Negative control corrected OD490 2# |
Negative control corrected OD490 3# |
Negative control corrected OD490 Average |
Negative control corrected final OD490 |
Average OD |
Positive control |
1 |
1.399 |
1.396 |
1.398 |
1.398 |
1.398 |
1.110 |
1 |
1.069 |
1.060 |
1.058 |
1.063 |
1.063 |
||
1 |
0.871 |
0.870 |
0.870 |
0.871 |
0.871 |
||
Test item |
1 |
0.418 |
0.413 |
0.412 |
0.415 |
0.415 |
0.474 |
1 |
0.495 |
0.495 |
0.499 |
0.497 |
0.497 |
||
1 |
0.514 |
0.511 |
0.504 |
0.510 |
0.510 |
Calculations are made without rounding off.
# OD490 values corrected for the mean final negative control permeability (-0.018).
Table 5: In Vitro Irritancy Score
Treatment |
Final Opacity2 |
Final OD4902 |
In vitro Irritancy Score1 |
Negative control |
-1.2* |
0.586* |
7.6* |
0.2 |
-0.016 |
0.0 |
|
-0.9 |
-0.020 |
-1.2 |
|
Positive control |
19 |
1.398 |
40 |
16 |
1.063 |
32 |
|
22 |
0.871 |
35 |
|
Test item |
7.8 |
0.415 |
14.1 |
9.0 |
0.497 |
16.5 |
|
9.1 |
0.510 |
16.7 |
1 In vitro irritancy score (IVIS) = opacity value + (15 x OD490 value).
2 Positive control and test item are corrected for the negative control.
* Excluded from analysis.
Table 6: Historical
Control Data for the BCOP Studies
|
Negative control |
Positive control |
||
|
Opacity |
Permeability |
In vitro Irritancy Score |
In vitro Irritancy Score |
Min |
-2.50 |
-0.017 |
-2.50 |
26 |
Max |
3.70 |
0.065 |
4.00 |
86 |
Mean |
0.86 |
0.002 |
0.89 |
50 |
SD |
1.26 |
0.009 |
1.28 |
14 |
n |
143 |
143 |
143 |
143 |
SD = Standard deviation
n = Number of observations
The above mentioned historical control data range of the controls were obtained by collecting all data over the period of May 2018 to May 2021.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation
Dimethoxy(dimethyl)silane was evaluated for its ability to induce skin irritation on human three dimensional epidermal models (EPISKIN Small model (EPISKIN-SMTM) and EpiDerm (EPI-SIT)) according to OECD TG 439 and in compliance with GLP (Charles River Laboratories, 2022).
In the EPISKIN test, 25 µL of the undiluted test item was applied directly on top of three skin tissues (EPISKIN-SMTM). Three tissues were treated with 25 µLphosphate buffered saline (PBS, negative control) and three tissues with 25 µL 5%sodium dodecyl sulfate (SDS, positive control). After the exposure period of 15 ± 0.5 min at room temperature, the tissues were washed followed by a 42±1 h post-incubation period at 37°C. After incubation, determination of the cytotoxic (irritancy) effect was performed. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) at the end of the treatment. No colour interference or reduction of MTT by the test item was concluded based on the respective pre-tests.
Skin irritation is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 15 ± 0.5 min treatment with the test item compared to the negative control tissues was 114%. Since the mean relative tissue viability for the test item was above 50%, the test item is considered to be non-irritant in the EPISKIN test.
The positive control had a mean cell viability of 2.5% after 15 ± 0.5 min exposure. The absolute mean OD570 (optical density at 570 nm) of the negative control (PBS) tissues was within the laboratory historical control data range. The standard deviation value of the percentage viability of three tissues treated identically was ≤ 16%, indicating that the test system functioned properly.
In the EpiDerm test, the test item was applied undiluted (30 µL) directly on top of three skin tissues (EPI-SIT) for 60±1 min (35 ± 1.0 min at 37.0 ± 1.0°C and the remaining period at room temperature). Three tissues were treated with 30 µL Dulbecco’s phosphate buffered saline (DPBS, negative control) and three tissues with 30 µL 5% sodium dodecyl sulfate (SDS, positive control). After a 42 h post-incubation period at 37°C, determination of the cytotoxic (irritancy) effect was performed via MTT assay. The relative mean tissue viability obtained after 60±1 min treatment with the test item compared to the negative control tissues was 76%. Since the mean relative tissue viability for the test item was above 50%, the test item is considered to be non-irritant in the EpiDerm test.
The positive control (5% SDS) had a mean cell viability after 60±1 min exposure of 3.1%. One negative control (DPBS) treated skin was considered to be an outlier and results of this skin were omitted (absolute mean OD570 of 0.761). The absolute mean OD570 of the remaining two negative control tissues was within the laboratory historical control data range. The standard deviation value of the percentage viability of three (test substance and positive control) or two (negative control) tissues treated identically was ≤ 18%, and thus the in vitro skin irritation test met the acceptability criteria.
In conclusion, dimethoxy(dimethyl)silane is non-irritant in the in vitro skin irritation test under the experimental conditions of the EPISKIN Small ModelTM and EpiDerm Skin Model.
Eye irritation
The eye hazard potential of dimethoxy(dimethyl)silane was tested in a BCOP test according to OECD TG 437 and in compliance with GLP (Charles River Laboratories, 2022).
After a first opacity measurement, 750 µL of the neat test item, the positive control (ethanol) or the negative control (physiological saline) was applied for 10 min 32 ± 1 °C on the top of three fresh corneas. After the incubation phase the test item, the positive, and the negative controls were each washed from the corneas. Further, the corneas were incubated for another 120 minutes at 32 ± 1 °C. Afterwards, opacity was measured a second time. After the opacity measurements, permeability of the corneas was determined by measuring spectrophotometrically the transfer of sodium fluorescein after incubation in a horizontal position for 90 min at 32 ± 1 °C.
The individual in vitro irritancy scores (IVIS) for the negative controls (physiological saline) ranged from 0.0 to -1.2. One of the negative control eyes was excluded from the analysis since the permeability was increased. This resulted in an IVIS above the cut-off value of 3.0. The mean of the two remaining eyes met the acceptability criteria, therefore, this had no impact on the study validity.
The individual positive control (ethanol) in vitro irritancy scores ranged from 32 to 40. The corneas treated with the positive control item were observed to be turbid after the 10 minutes of treatment.
The corneas treated with the test item showed opacity values ranging from 7.8 to 9.1 and permeability values ranging from 0.415 to 0.510. The corneas were turbid after the 10 minutes of treatment with the test item. No pH effect of the test item was observed on rinsing of the corneas with MEM (with phenol red). Hence, the in vitro irritancy scores ranged from 14 to 17 after 10 minutes of treatment with the test item.
In conclusion, dimethoxy(dimethyl)silane induced an IVIS > 3 ≤ 55, indicating that no definitive prediction on ocular irritation can be made.
A further in vitro eye irritation study is planned for dimethoxy(dimethyl)silane to come to a final conclusion on its eye irritation properties.
As an interim measure, the hazard assessment on eye irritation was performed based on available data from the structural analogues trimethoxy(methyl)silane (CAS 1185-55-3) and triethoxy(methyl)silane (CAS 2031-67-6).
Details on read across justifications can be found in the attached justification in the respective target entry and in the overall justification for grouping of substances attached in IUCLID Section 13.
The available study for eye irritation with the structural analogue substance trimethoxy(methyl)silane (CAS 1185-55-3) was conducted in accordance with OECD TG 405 and to GLP (Kreiling and Jung, 1991). Trimethoxy(methyl)silane was found to be not irritating to rabbit eyes.
Furthermore, an eye irritation study on the structural analogue
substance triethoxy(methyl)silane (CAS 2031-67-6) which was not in
compliance with GLP, but was equivalent or similar to OECD TG 405,
showed that triethoxy(methyl)silane was not irritating to rabbit eyes.
Only minor, transient eye irritation was observed following instillation
of the test material into the eyes of six rabbits. The Draize score of
0.06 out of 3 indicates that triethoxy(methyl)silane would not be
considered irritating to the eyes of rabbits (Bushy Run Research Center,
1981). All studies are in agreement of the lack of eye irritation
potential of the structural analogue substances,
trimethoxy(methyl)silane and triethoxy(methyl)silane. This therefore
strengthens the overall assumption that the registered substance,
dimethoxy(dimethyl)silane, will not be an eye irritant.
Justification for classification or non-classification
The available data on irritation / corrosion of the registration substance and structural analogue substances, trimethoxy(methyl)silane and triethoxy(methyl)silane, respectively, do not meet the criteria for classification according to Regulation (EC) No 1272/2008, and are therefore conclusive but not sufficient for classification of the registered substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
